Eli Lilly stock plunges. To find out what lies ahead for Eli Lilly in this increasingly competitive environment, visit CDS.

Today’s Forbes Daily covers Eli Lilly’s historic loss, the new GPT-5 for OpenAI’s ChatGPT, reactions to Instagram’s new map ...

Padrão dos Descobrimentos in Lisbon Portugal Following the Genoese and Venetians, the Portuguese (Lusitanians) emerged as the ...

Renowned economist Richard Werner challenges traditional views on banks, stating they have the unique power to create money.

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

A series of lawsuits have been filed in Marion County court alleging that drug manufacturer Eli Lilly downplayed the side ...

The company said it plans to develop its new Chai‑2 platform to design, from square one, completely new antibodies for ...

After a rough reception and a rebrand to support users of GLP-1 drugs, Peoplehood is selling its assets to WeightWatchers.

Elanco beats Q2 expectations and raises 2025 guidance as strong Pet Health sales and FX tailwinds offset tariff and ...

This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members ...

In what Epic Games’ CEO describes as a “[t]otal victory in the Epic v. Google appeal”, on July 31, the United States Court of Appeals for the ...